$ACST I expected Capre to lower trigs by 30% or better. It did! I expected plain low glycemic starch in control to allow stains to perform as they should - lowering trigs rather than raising them as happened in all Vascepa studies over the same time frames. I did not, however, expect a 27% reduction in control. This calls into question every OMEGA-3 trial ever conducted and the results of every therapeutic ever approved. And yet, somehow, D'Alvise points to 5 aberrant trial sites without giving us the data she has to prove those sites are culpable. Likely, they’re not!